Fate Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Fate Therapeutics, Inc.‘s stocks are currently a part of 235 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 100.51M shares of Fate Therapeutics, Inc.. Compared to the previous quarter, the number grew by 3.87% or 3.74M shares more. As for the holding position changes, 39.15% (92) of current hedge fund investors increased the number of shares held, 29.36% (69) of current holders sold a part of the shares held, and 15.32% (36) closed the holdings completely. 35 hedge funds are new holders of Fate Therapeutics, Inc. stock in Q1 2022, it is 14.89% of total holders.
Hedge funds holding Fate Therapeutics (Q2 2017 – Q1 2022)
| Q2 2017 | 58 |
|---|---|
| Q3 2017 | 71 |
| Q4 2017 | 78 |
| Q1 2018 | 89 |
| Q2 2018 | 102 |
| Q3 2018 | 117 |
| Q4 2018 | 121 |
| Q1 2019 | 122 |
| Q2 2019 | 134 |
| Q3 2019 | 148 |
| Q4 2019 | 146 |
| Q1 2020 | 156 |
| Q2 2020 | 201 |
| Q3 2020 | 209 |
| Q4 2020 | 246 |
| Q1 2021 | 254 |
| Q2 2021 | 266 |
| Q3 2021 | 254 |
| Q4 2021 | 240 |
| Q1 2022 | 235 |
Hedge funds changes in Fate Therapeutics positions (Q2 2017 – Q1 2022)
| Q2 2017 | 21 | 16 | 11 | 13 | -3 |
|---|---|---|---|---|---|
| Q3 2017 | 17 | 18 | 21 | 3 | 12 |
| Q4 2017 | 22 | 26 | 18 | 15 | -3 |
| Q1 2018 | 26 | 34 | 20 | 14 | -5 |
| Q2 2018 | 31 | 38 | 20 | 18 | -5 |
| Q3 2018 | 29 | 43 | 27 | 14 | 4 |
| Q4 2018 | 25 | 51 | 33 | 21 | -9 |
| Q1 2019 | 15 | 41 | 44 | 14 | 8 |
| Q2 2019 | 26 | 37 | 42 | 12 | 17 |
| Q3 2019 | 27 | 56 | 41 | 13 | 11 |
| Q4 2019 | 34 | 57 | 35 | 30 | -10 |
| Q1 2020 | 36 | 45 | 57 | 24 | -6 |
| Q2 2020 | 57 | 73 | 50 | 12 | 9 |
| Q3 2020 | 29 | 88 | 63 | 20 | 9 |
| Q4 2020 | 65 | 71 | 95 | 29 | -14 |
| Q1 2021 | 48 | 89 | 90 | 36 | -9 |
| Q2 2021 | 48 | 100 | 76 | 35 | 7 |
| Q3 2021 | 36 | 100 | 81 | 45 | -8 |
| Q4 2021 | 35 | 95 | 70 | 48 | -8 |
| Q1 2022 | 35 | 92 | 69 | 36 | 3 |
Hedge funds changes in Fate Therapeutics stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 1,000 |
| Q4 2017 | 46,000 | 8,000 |
| Q1 2018 | 1,256,000 | 594,000 |
| Q2 2018 | 2,341,000 | 1,605,000 |
| Q3 2018 | 2,765,000 | 2,430,000 |
| Q4 2018 | 2,571,000 | 2,429,000 |
| Q1 2019 | 4,547,000 | 6,594,000 |
| Q2 2019 | 6,454,000 | 6,591,000 |
| Q3 2019 | 3,973,000 | 4,507,000 |
| Q4 2019 | 13,315,000 | 8,711,000 |
| Q1 2020 | 11,695,000 | 4,791,000 |
| Q2 2020 | 7,171,000 | 7,702,000 |
| Q3 2020 | 6,212,000 | 7,442,000 |
| Q4 2020 | 17,157,000 | 19,455,000 |
| Q1 2021 | 23,303,000 | 25,833,000 |
| Q2 2021 | 13,482,000 | 21,092,000 |
| Q3 2021 | 8,950,000 | 25,519,000 |
| Q4 2021 | 18,853,000 | 10,615,000 |
| Q1 2022 | 9,696,000 | 5,772,000 |